Method and composition for alleviating tumor symptoms
GB201107553D0
Composition and methods for the treatment of neuroendocrine and pitutitary tumoars
GB201007024D0
Compositions and methods for the treatment of neuroendocrine and pituitary tumours
GB0428103D0
Chemical Process
GB0421296D0
Bioreductively-activated prodrugs
GB0421294D0
Bioreductively-activated prodrugs
GB0421295D0
Bioreductively-activated prodrugs
EP1658084A2
Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
GB0410817D0
Vascular damaging therapy
GB0329771D0
Chemical processes & intermediates
GB0306908D0
Bioreductively activated stilbene prodrugs
GB0306907D0
Boireductively-activated prodrugs
GB0223379D0
Combination therapy
CZ200331A3
Colchinol derivatives functioning as angiogenesis inhibitors, process of their preparation and pharmaceutical composition in which the derivatives are comprised
US6720323B2
Colchinol derivatives as angiogenesis inhibitors
EP1301497A1
Colchinol derivatives as vascular damaging agents
HU0300576A2
Divided dose therapies with vascular damaging activity
